The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 02, 2007
Filed:
Mar. 25, 2003
Jong-woo Kim, Anyang-si, KR;
Sang-wook Lee, Anyang-si, KR;
Geun-hyung Lee, Yongin-si, KR;
Jae-jin Han, Yongin-si, KR;
Sang-jin Park, Yongin-si, KR;
Eul-yong Park, Anyang-si, KR;
Joong-chul Shin, Yongin-si, KR;
Jong-Woo Kim, Anyang-si, KR;
Sang-Wook Lee, Anyang-si, KR;
Geun-Hyung Lee, Yongin-si, KR;
Jae-Jin Han, Yongin-si, KR;
Sang-Jin Park, Yongin-si, KR;
Eul-Yong Park, Anyang-si, KR;
Joong-Chul Shin, Yongin-si, KR;
B & C Biopharm, , KR;
Abstract
The present invention relates to 6-(4-substituted-anilino)pyrimidine derivatives useful as an antiviral agent, and more particularly novel 6-(4-substituted-anilino)pyrimidine derivatives having an excellent inhibitory effect on replication of Hepatitis C virus; HCV), represented by the following formula I: in which R represents a C-Cstraight or branched alkoxycarbonyl group, heterocycliccarbonyl group or carboxyalkyl group; and pharmaceutically acceptable salts thereof, a preparation method thereof, and an antiviral pharmaceutical composition comprising the compound as an effective ingredient. The 6-(4-substituted-anilino)pyrimidine derivatives according to the present invention have an excellent inhibitory effect on replication of Hepatitis C virus (HCV) and thus can be advantageously used as a therapeutic or prophylactic agent of hepatitis C.